Lights and shadows of SARS-CoV-2 infection risk assessment in endoscopy
- 13 June 2020
- journal article
- letter
- Published by Elsevier BV in Digestive and Liver Disease
- Vol. 52 (8), 816-818
- https://doi.org/10.1016/j.dld.2020.06.013
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Tonsillar Kaposi sarcoma in a renal transplant patientTransplant Infectious Disease, 2020
- Redesign of a GI endoscopy unit during the COVID-19 emergency: A practical modelDigestive and Liver Disease, 2020
- Impact of the COVID-19 pandemic on Gastroenterology Divisions in Italy: A national surveyDigestive and Liver Disease, 2020
- Endoscopy during the Covid-19 outbreak: experience and recommendations from a single center in a high-incidence scenarioDigestive and Liver Disease, 2020
- Low risk of COVID-19 transmission in GI endoscopyGut, 2020
- ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemicEndoscopy, 2020
- Novel Coronavirus: Current Understanding of Clinical Features, Diagnosis, Pathogenesis, and Treatment OptionsPathogens, 2020
- Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period.2020
- SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected PatientsThe New England Journal of Medicine, 2020
- Convalescent plasma as a potential therapy for COVID-19The Lancet Infectious Diseases, 2020